Search Results

BPTU 2 mg  | 99.89%

TargetMol

Allosteric antagonist of P2Y1 (EC50 = 0.06-0.3 μM). Non-nucleotide ligand. Binds receptor outside of the helical bundle. Blocks inhibition of spontaneous contraction of rat and mouse colon induced by electrical field stimulation, nicotine and P2Y agonists. Antithrombotic; reduces platelet aggregation.

More Information Supplier Page

Octreotide Acetate 200 mg  | 99.57%

TargetMol

Octreotide Acetate (Sandostatin) is a potent, long-acting synthetic somatostatin octapeptide analog that inhibits secretion of growth hormone.

More Information Supplier Page

Octreotide Acetate 100 mg  | 99.57%

TargetMol

Octreotide Acetate (Sandostatin) is a potent, long-acting synthetic somatostatin octapeptide analog that inhibits secretion of growth hormone.

More Information Supplier Page

MK-8617 2 mg  | Purity Not Available

TargetMol

MK-8617 is an orally available HIF PHD1 3 pan-inhibitor, inhibiting PHD1/2/3 (IC50: 1.0/1.0/14 nM).

More Information Supplier Page

GSK2981278 25 mg  | 99.78%

TargetMol

GSK2981278 is a highly potent and selective inverse agonist of retinoic acid receptor-related orphan receptor gamma (ROR gamma).

More Information Supplier Page

L-Argininamide dihydrochloride 200 mg  | 100.00%

TargetMol

L-Argininamide (L-Arm) is used as a model compound in studies of the physicochemical characteristic of ligand binding DNA aptamers and their potential development as fluorescent aptasensors.

More Information Supplier Page

BPTU 5 mg  | 99.89%

TargetMol

Allosteric antagonist of P2Y1 (EC50 = 0.06-0.3 μM). Non-nucleotide ligand. Binds receptor outside of the helical bundle. Blocks inhibition of spontaneous contraction of rat and mouse colon induced by electrical field stimulation, nicotine and P2Y agonists. Antithrombotic; reduces platelet aggregation.

More Information Supplier Page